# Antibiotics Study in Preterm Premature Rupture of the Membranes

> **NCT01401179** · PHASE3 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 101 (actual)

## Conditions studied

- Preterm Premature Rupture of the Membranes

## Interventions

- **DRUG:** cefazolin, erythromycin, clarithromycin

## Key facts

- **NCT ID:** NCT01401179
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401179, "Antibiotics Study in Preterm Premature Rupture of the Membranes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01401179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*